6891 Stock Overview
Locus Cell Co., Ltd. focuses on contract development and manufacturing organization (CDMO) services for cell products in Taiwan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Locus Cell Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$32.40 |
| 52 Week High | NT$49.15 |
| 52 Week Low | NT$22.20 |
| Beta | 0 |
| 1 Month Change | 30.12% |
| 3 Month Change | 9.46% |
| 1 Year Change | -29.79% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -34.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6891 | TW Life Sciences | TW Market | |
|---|---|---|---|
| 7D | 15.7% | -0.2% | -2.3% |
| 1Y | -29.8% | -24.0% | 27.2% |
Return vs Industry: 6891 underperformed the TW Life Sciences industry which returned -24% over the past year.
Return vs Market: 6891 underperformed the TW Market which returned 27.2% over the past year.
Price Volatility
| 6891 volatility | |
|---|---|
| 6891 Average Weekly Movement | 7.6% |
| Life Sciences Industry Average Movement | 5.1% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 6891's share price has been volatile over the past 3 months.
Volatility Over Time: 6891's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 33 | Yu-Hsiang Chang | www.locus-cell.com |
Locus Cell Co., Ltd. focuses on contract development and manufacturing organization (CDMO) services for cell products in Taiwan and internationally. It offers tissue engineering CDMO services for adipose-derived stem cells, nerve cells, chondrocytes, fibroblasts, epithelial cells, 3D printing cell products, and other cell products; and regenerative medical product CDMO services, such as CAR-T, CAR-NK, iPSC, MSC/ADSC, and other cell types. The company is based in New Taipei City, Taiwan.
Locus Cell Co., Ltd. Fundamentals Summary
| 6891 fundamental statistics | |
|---|---|
| Market cap | NT$6.48b |
| Earnings (TTM) | -NT$96.89m |
| Revenue (TTM) | NT$406.00k |
Over9,999x
P/S Ratio-66.9x
P/E RatioIs 6891 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6891 income statement (TTM) | |
|---|---|
| Revenue | NT$406.00k |
| Cost of Revenue | NT$235.00k |
| Gross Profit | NT$171.00k |
| Other Expenses | NT$97.07m |
| Earnings | -NT$96.89m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.48 |
| Gross Margin | 42.12% |
| Net Profit Margin | -23,865.52% |
| Debt/Equity Ratio | 0% |
How did 6891 perform over the long term?
See historical performance and comparison